PortfoliosLab logoPortfoliosLab logo
WRNA.DE vs. BATT.L
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

WRNA.DE vs. BATT.L - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in WisdomTree BioRevolution UCITS ETF USD Acc (WRNA.DE) and L&G Battery Value-Chain UCITS ETF (BATT.L). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

WRNA.DE is traded in EUR, while BATT.L is traded in USD. To make them comparable, the BATT.L values have been converted to EUR using the latest available exchange rates.

Returns By Period

In the year-to-date period, WRNA.DE achieves a 10.48% return, which is significantly lower than BATT.L's 36.71% return.


WRNA.DE

1D
4.08%
1M
4.18%
YTD
10.48%
6M
10.41%
1Y
48.70%
3Y*
0.92%
5Y*
10Y*

BATT.L

1D
-2.68%
1M
-0.84%
YTD
36.71%
6M
40.40%
1Y
124.24%
3Y*
24.78%
5Y*
17.27%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

WRNA.DE vs. BATT.L - Yearly Performance Comparison


2026 (YTD)20252024202320222021
WRNA.DE
WisdomTree BioRevolution UCITS ETF USD Acc
10.48%9.13%-10.92%-3.37%-22.01%-0.98%
BATT.L
L&G Battery Value-Chain UCITS ETF
36.71%51.09%5.32%5.54%-8.86%-0.55%

Correlation

The correlation between WRNA.DE and BATT.L is 0.41, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.41

Correlation (3Y)
Calculated over the trailing 3-year period

0.48

Correlation (All Time)
Calculated using the full available price history since Dec 10, 2021

0.50

The correlation between WRNA.DE and BATT.L has been stable across timeframes, ranging from 0.41 to 0.50 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

WRNA.DE vs. BATT.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WRNA.DE
WRNA.DE Risk / Return Rank: 5656
Overall Rank
WRNA.DE Sharpe Ratio Rank: 5252
Sharpe Ratio Rank
WRNA.DE Sortino Ratio Rank: 5252
Sortino Ratio Rank
WRNA.DE Omega Ratio Rank: 4848
Omega Ratio Rank
WRNA.DE Calmar Ratio Rank: 7373
Calmar Ratio Rank
WRNA.DE Martin Ratio Rank: 5656
Martin Ratio Rank

BATT.L
BATT.L Risk / Return Rank: 9595
Overall Rank
BATT.L Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
BATT.L Sortino Ratio Rank: 9393
Sortino Ratio Rank
BATT.L Omega Ratio Rank: 9292
Omega Ratio Rank
BATT.L Calmar Ratio Rank: 9696
Calmar Ratio Rank
BATT.L Martin Ratio Rank: 9595
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WRNA.DE vs. BATT.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution UCITS ETF USD Acc (WRNA.DE) and L&G Battery Value-Chain UCITS ETF (BATT.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


WRNA.DEBATT.LDifference
Sharpe ratioReturn per unit of total volatility

-2.47

Sortino ratioReturn per unit of downside risk

-2.22

Omega ratioGain probability vs. loss probability

1.30

1.62

-0.32

Calmar ratioReturn relative to maximum drawdown

3.61

9.93

-6.31

Martin ratioReturn relative to average drawdown

9.63

33.85

-24.22

WRNA.DE vs. BATT.L - Sharpe Ratio Comparison

The current WRNA.DE Sharpe Ratio is 1.75, which is lower than the BATT.L Sharpe Ratio of 4.22. The chart below compares the historical Sharpe Ratios of WRNA.DE and BATT.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


WRNA.DEBATT.LDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.75

4.22

-2.47

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.72

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.20

0.77

-0.97

Drawdowns

WRNA.DE vs. BATT.L - Drawdown Comparison

The maximum WRNA.DE drawdown since its inception was -52.35%, which is greater than BATT.L's maximum drawdown of -37.26%. Use the drawdown chart below to compare losses from any high point for WRNA.DE and BATT.L.


Loading charts...

Drawdown Indicators


WRNA.DEBATT.LDifference

Max Drawdown

Largest peak-to-trough decline

-52.35%

-37.26%

-15.09%

Max Drawdown (1Y)

Largest decline over 1 year

-13.42%

-12.45%

-0.97%

Max Drawdown (3Y)

Largest decline over 3 years

-40.06%

-33.16%

-6.90%

Max Drawdown (5Y)

Largest decline over 5 years

-33.16%

Current Drawdown

Current decline from peak

-20.73%

-4.30%

-16.43%

Average Drawdown

Average peak-to-trough decline

-27.26%

-9.04%

-18.22%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.04%

3.66%

+1.38%

Volatility

WRNA.DE vs. BATT.L - Volatility Comparison

The current volatility for WisdomTree BioRevolution UCITS ETF USD Acc (WRNA.DE) is 6.73%, while L&G Battery Value-Chain UCITS ETF (BATT.L) has a volatility of 10.92%. This indicates that WRNA.DE experiences smaller price fluctuations and is considered to be less risky than BATT.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


WRNA.DEBATT.LDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.73%

10.92%

-4.19%

Volatility (6M)

Calculated over the trailing 6-month period

17.21%

23.20%

-5.99%

Volatility (1Y)

Calculated over the trailing 1-year period

27.70%

29.30%

-1.60%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

24.22%

24.06%

+0.16%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

24.22%

24.19%

+0.03%

WRNA.DE vs. BATT.L - Expense Ratio Comparison

WRNA.DE has a 0.45% expense ratio, which is lower than BATT.L's 0.49% expense ratio.


Dividends

WRNA.DE vs. BATT.L - Dividend Comparison

Neither WRNA.DE nor BATT.L has paid dividends to shareholders.


Tickers have no history of dividend payments

Frequently Asked Questions


WRNA.DE and BATT.L have a correlation of 0.41, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, WRNA.DE is cheaper at 0.45% per year. The better choice depends on whether you care most about return, fees, risk, or income.

WRNA.DE is cheaper with a 0.45% expense ratio, compared with 0.49% for BATT.L.

WRNA.DE is categorized as Health & Biotech Equities, while BATT.L is Alternative Energy Equities. WRNA.DE tracks WisdomTree BioRevolution ESG Screened, while BATT.L tracks Solactive Battery Value-Chain Index. They also come from different issuers: WisdomTree and Legal & General. Their fees differ too: 0.45% for WRNA.DE and 0.49% for BATT.L.

Portfolio Optimizer

Find the right allocation for WRNA.DE and BATT.L

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer